Related Experiment Video

Updated: May 9, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Therapeutic cancer vaccines: past, present, and future

Chunqing Guo1, Masoud H Manjili, John R Subjeck

  • 1Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

Advances in Cancer Research
|July 23, 2013
PubMed

Insights

The first therapeutic cancer vaccine offers a new immunotherapy option for late-stage cancers. Research is ongoing to improve vaccine efficacy and overcome immune suppression for better cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines are a promising active immunotherapy approach for late-stage cancers.
  • Recent FDA approval of the first therapeutic cancer vaccine marks a significant advancement in cancer treatment.
  • This breakthrough facilitates the development of novel vaccines with enhanced anticancer efficacy.

Purpose of the Study:

  • To review diverse therapeutic cancer vaccine platforms and targets.
  • To discuss preclinical and clinical studies of these vaccines.
  • To explore strategies for overcoming tumor-induced immune suppression to improve vaccine potency.

Main Methods:

  • Literature review of therapeutic cancer vaccines.
  • Analysis of preclinical and clinical trial data.
  • Examination of mechanisms of tumor-induced immune suppression.

Main Results:

  • Diverse vaccine platforms and targets are under investigation.
  • Clinical trials show promising results, leading to regulatory approval.
  • Tumor-induced immune suppression is a key challenge impacting vaccine efficacy.

Conclusions:

  • Therapeutic cancer vaccines represent a viable new treatment modality.
  • Further research is needed to optimize vaccine design and overcome immune evasion.
  • Strategies to counteract tumor immunosuppression are crucial for durable antitumor responses.
Keywords:
Cancer vaccineImmune modulatorImmunosuppressionImmunotherapyTumor microenvironmentTumor-associated antigen

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...